“Pediatric Vaccines market for United States is a multi-billion dollar industry. The value of United States pediatric vaccines market alone is expected to reach more than US$ 18 Billion by 2020. The United States Pediatric vaccines market is driven by favorable demographics, growing public acceptance and product innovation. Varicella and Pneumococcal vaccines (PCV) control the highest and second highest market share in United States respectively. Together both of these vaccines control more than 50% market share.
In number of cases Polio, MMR, Diphtheria and Tetanus cases have diminished significantly from the year 2001 till 2013. In United States, DTP are the highly penetrated vaccines in pediatric vaccines market which contributed more than 100 Million doses in 2014. Polio and MMR are also mostly used vaccines together they consumed more than 150 Million doses in 2014. It is predicted that these three vaccines will bolster the usable pattern in the United States.
The United States pediatric vaccines are expected to remain highly active in the future, fueled by the encouragement and financing from Governments and other health organizations.
This is 8th edition report on Vaccines Market & 3rd edition on Pediatric Vaccines Market by Renub Research. Report titled “” United States Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases & Forecast” talks about the pediatric vaccines. The report provides information on all the Ten (10) Pediatric Vaccines Market, Doses, Number of Children Being Vaccinated and Number of Cases in United States. This report covers in detail all aspects of past, present and future scenario. The report also entails major factors driving the Pediatric vaccines market and challenges of Pediatric vaccines market.
Ten (10) Pediatric Vaccines Covered in this Report are as follows:
1. Measles, Mumps & Rubella (MMR) Vaccines
2. Haemophilus Influenzae Type B (HIB) Vaccines
3. Polio Vaccines
4. Diphtheria Tetanus & Pertussis (DTaP) Vaccines
5. Pneumococcal Vaccines
6. Rotavirus Vaccines
7. Hepatitis B Pediatric Vaccines
8. Hepatitis A Pediatric Vaccines
9. Varicella / Chicken Pox Vaccines
10. Influenza Pediatric Vaccines
All the Pediatric Vaccines in this Report have been studied from Four View Points:
1. Number of Cases
2. Number of Doses
3. Number of Children Being Vaccinated
4. Market Size for all 10 Pediatric Vaccines
Key Topics Covered in the Report
• United States – Pediatric Vaccines Market & Forecast
• United States – Pediatric Vaccines Market Share & Forecast
• United States – Pediatric Disease Cases
• Pediatric Vaccines Doses and Forecast
• Number of Children Being Vaccinated
• Market Size for all 10 Pediatric Vaccines
• Growth Drivers of Pediatric Vaccines Market
• Challenges of Pediatric Vaccines Market
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
”
“Table of Contents
1. Executive Summary
2. United States – Pediatric Vaccines Market & Forecast
3. United States – Pediatric Vaccines Market Share & Forecast
4. United States – Pediatric Vaccines Cases, Doses, Immunization Coverage, Market & Forecast
4.1 United States – Measles, Mumps & Rubella (MMR) Vaccines & Forecast
4.1.1 Number of Measles, Mumps & Rubella (MMR) Cases
4.1.2 Number of Measles, Mumps & Rubella (MMR) Vaccines Doses
4.1.3 Measles, Mumps & Rubella (MMR) – Number of Children Being Vaccinated
4.1.4 Market Size of Measles, Mumps & Rubella (MMR) Vaccines
4.2 United States – Haemophilus Influenzae Type B (HIB) Vaccines & Forecast
4.2.1 Number of Haemophilus Influenzae Type B (HIB) Vaccines Doses
4.2.2 Haemophilus Influenzae Type B (HIB) – Number of Children Being Vaccinated
4.2.3 Market Size of Haemophilus Influenzae Type B (HIB) Vaccines
4.3 United States – Polio Vaccines & Forecast
4.3.1 Number of Polio Cases
4.3.2 Number of Polio Vaccines Doses
4.3.3 Polio Vaccines – Number of Children Being Vaccinated
4.3.4 Market Size of Polio Vaccines
4.4 United States – Diphtheria, Tetanus & Pertussis (DTap) Vaccines & Forecast
4.4.1 Number of Diphtheria, Tetanus & Pertussis (DTaP) Cases
4.4.2 Number of Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Doses
4.4.3 Diphtheria, Tetanus & Pertusis (DTaP) – Number of Children Being Vaccinated
4.4.4 Market Size of Diphtheria, Tetanus & Pertussis (DTaP) Vaccines
4.5 United States – Pneumococcal Vaccines & Forecast
4.5.1 Number of Pneumococcal Vaccines Doses
4.5.2 Pneumococcal – Number of Children Being Vaccinated
4.5.3 Market Size of Pneumococcal Vaccines
4.6 United States – Rotavirus Vaccines & Forecast
4.6.1 Number of Rotavirus Vaccines Doses
4.6.2 Rotavirus – Number of Children Being Vaccinated
4.6.3 Market Size of Rotavirus Vaccine
4.7 United States – Hepatitis B Pediatric Vaccines & Forecast
4.7.1 Number of Hepatitis B Pediatric Vaccines Doses
4.7.2 Hepatitis B Pediatric – Number of Children Being Vaccinated
4.7.3 Market Size of Hepatitis B Pediatric Vaccines
4.8 United States – Hepatitis A Pediatric Vaccines & Forecast
4.8.1 Number of Hepatitis A Pediatric Vaccines Doses
4.8.2 Hepatitis A Pediatric – Number of Children Being Vaccinated & Forecast
4.8.3 Market Size of Hepatitis A Pediatric Vaccines
4.9 United States – Varicella / Chicken Pox Vaccines & Forecast
4.9.1 Number of Varicella / Chicken Pox Vaccines Doses
4.9.2 Varicella/Chicken Pox – Number of Children Being Vaccinated
4.9.3 Market Size of Varicella/Chicken Pox Vaccines
4.10 United States – Influenza Pediatric Vaccines & Forecast
4.10.1 Number of Influenza Pediatric Vaccines Doses
4.10.2 Influenza Pediatric Vaccines – Number of Children Being Vaccinated
4.10.3 Market Size of Influenza Pediatric Vaccines
5. Growth Drivers of United States Pediatric Vaccines Market
5.1 Increase Immunization Rates & Reduce Preventable Infectious Diseases
5.2 Increasing Vaccine Availability in United States
5.3 The Vaccine Safety Data link Project
5.4 The Vaccine Injury Compensation Program
5.5 Transforming of Vaccine Technologies
5.6 Continuous Focus on Effective Communication Strategies
6. Challenges of United States Pediatric Vaccines Market
6.1 Impediment in Pediatric Vaccine Research & Development
6.2 Barriers to New Entrants in the Pediatric Vaccines Market
6.3 Hurdles to Optimal use of Licensed Vaccines
6.3.1 Technical Obstacles
6.3.2 Economic obstacles
6.3.3 Cultural Obstacles
6.4 Complexity of Vaccine Development & Approval System Thwarts Product Development
6.4.1 Legal Obstacles
6.4.2 General Technical Barriers
6.4.3 Economic Barriers
6.4.4 Regulatory Barriers
6.5 Shortening the Timeline for Vaccine Development
6.6 Refusal / Resistance to Vaccination
6.6.1 Vaccine Adverse Event Reporting System
6.7 Vaccine Shortages and Delays
6.8 Emerging Issues in Immunization and Infectious Diseases in United States
“
